<DOC>
	<DOC>NCT01302925</DOC>
	<brief_summary>The purpose of this phase 1 trial is to investigate the local tolerability on the finger following exposure to PEP005 Gel 0.015% or 0.05% and hand washing once daily, for 2 or 3 consecutive days.</brief_summary>
	<brief_title>PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate Gel Followed by Hand Washing in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis, Actinic</mesh_term>
	<criteria>Must be male or female and at least 18 years of age Female patients must be of: nonchildbearing potential or if of childbearing potential then have a negative serum and urine pregnancy test and using effective contraception Ability to provide informed consent Have received treatment with immunomodulators, or interferon/interferon inducers or systematic medications that suppress the immune system in the last 4 weeks Exposed to prescribed systemic (take as tablet, injection etc) or topical (gel, cream, lotion) medication within the last 7 days Have any signs of skin irritation or damaged skin at or around the dominant index finger Have worked in an occupation with a high risk of being in contact with irritative material (eg. chemicals, painting) on their hands, especially fingers Those who are currently participating in any other clinical trial Those known or suspected of not being able to comply with the requirements of the protocol Females who are pregnant or are breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>